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ABSTRACT
Background and Purpose: In recent years, essential oils (EOs) have been reported to 
possess interesting anti-tumor, anti-mutagenic and anti-carcinogenic activities against 
various cancer cells. Therefore, we aimed to investigate potential biological activities 
of EOs from white poplar (Populus alba L., Salicaceae) and rosemary (Rosmarinus 
officinalis L., Lamiaceae). Material and Methods: EOs from P. alba L. and R. officinalis 
L. were extracted by hydrodistillation. MTT assay was carried out to determine the 
potential antiproliferative and cytotoxic properties of the essential oils as well as their 
corresponding IC50, and the inhibition (%) calculated. Antioxidant activity was determined 
using 2,2-diphenyl-2-picrylhydrazyl (DPPH) assay, and lipid peroxidation capacity was 
evaluated using thiobarbituric acid-reactive substances (TBARS) method, and the values 
were calculated using the standards. Results: The EOs were evaluated for their in vitro 
cytotoxic, antioxidant and lipid oxidation activities. Regarding cytotoxic activity rosemary 
essential oil possessed strong inhibition (IC50 = 3.06-7.38 µg/mL) of cell proliferation in 
comparison to that of P. alba L. (IC50 = 10.53-28.16 µg/mL). Additionally, EO from 
R. officinalis L. was found to have higher antioxidant and lipid peroxidation capacities 
with IC50 of 10.08 ± 0.15 and 1.76 ± 0.01,
 respectively. Conclusion: The results 
suggest that the EOs of both sources exhibited strong antiproliferative, cytotoxic and 
potent antioxidant properties and therefore they can have potential applications in the 
cancer treatment.
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INTRODUCTION
Medicinal and aromatic plants (MAPs) have 
been used in traditional medicine in all parts 
of  the world since the ancient times, and 
nowadays interest in using both different 
MAPs and products derived from MAPs 
have continued almost in all sectors and 
industries.1,2 In recent years, a large number 
of  secondary metabolites, including essential 
oils (EOs) are considered as valuable sources 
for ingredients in food and pharmaceutical 
industries, cosmetics and medicinal applica-
tions for prevention and/or treatment of  
many diseases including neurodegenerative 
diseases, rheumatoid arthritis, diabetes, 
respiratory diseases, cardiovascular diseases, 
cancers and inflammatory and oxidative 
diseases.2,3 EOs extracted from MAPs, 
contain 300 compounds such as limonene, 
𝛼-pinene, 𝛽-myrcene, 𝛽-elemene, caryoph-
yllene, humulene, 𝛼-farnesene, cembrene, 
kaurene, eucalyptol, camphorene, camphor, 
carveol, limonene oxide, caryophyllene oxide, 
farnesol, humulene epoxide, 𝛼-bisabolene 
oxide, carvacrol, catechol, eugenol, isopropyl 
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alcohol, butyl alcohol, perillyl alcohol, geraniol, nerol, 
safrole, sesquiterpenes, rosmarinic acid, nerolidol, 
benzophenone, bornyl acetate, ethyl acetate, vernolide, 
cinnamaldehyde, acetophenone, helenin, fumarin, 
benzofuran etc., that exhibit many biological properties 
including antibacterial, antifungal, antioxidant, antiulcer, 
antispasmodic, antiproliferative, antitumor, antihepato-
toxic, and others. EOs have thus become a focal point 
to improve and maintain human health needs and treat-
ment of  the diseases with less side effects.3-5
Previous researches both in vivo and in vitro showed that 
EOs possess major bioactive components and molecules, 
which have chemoprevention and cancer suppression 
activities. EOs have also been demonstrated to have 
potentials to fight against cancer cells by multiple path-
ways and mechanisms, including of  apoptosis and cell 
cycle arrest, angiogenesis and cell proliferation, of  DNA 
damage and to repair signaling and activation of  detoxi-
fication enzymes such as glutathione reductase, catalase 
glutathione, superoxide dismutase, peroxidase, etc.2-5
R. officinalis L., also known as rosemary, is native to the 
Mediterranean region and grown in many parts of  the 
world. Possesses a wide range of  biological activities 
and medicinal uses, particularly for the treatment of  
central nervous system complaints, liver, respiratory and 
genito-urinary disorders, cancer gastrointestinal and 
cardiovascular diseases.6-8 In addition to its medicinal 
uses, it has been used for culinary, food flavoring and 
spice, cosmetics, and perfumery applications.9,10 Recent 
studies revealed that rosemary EOs have greater biolog-
ical effects than its extracts since the EOs have higher 
contents of  major bioactive components, especially 
polyphenols and phenylpropanoids such as rosmarinic 
acid, carnosic acids, camphor, camphene, α-pinene, 
β-pinene, borneol, caryophyllene, limonene, terpin-
eol and myrcene.8-12 P. alba  L., known as white poplar, 
growing in a wide range of  environmental conditions, 
is belonging to the family Salicaceae and native to central 
and southern Europe.13 Although there were some 
previous investigations on the EO of  P. alba , to the 
best of  our knowledge, this is the first report of  its 
in vitro  anticancer and antiproliferative activities.
Contrary to rosemary extracts, which have been widely 
investigated for their anticancer effects, the EOs of  
rosemary and white poplar have not yet been thoroughly 
investigated for their biological activities especially 
antioxidant, antiproliferative and cytotoxic properties. 
Therefore, we have evaluated potential antioxidant 
properties, lipid peroxidation capacity, in vitro cytotoxic 
and antiproliferative activities of  EOs extracted from 
P. alba L. and R. officinalis L. against three human 
cancer cell lines: A549 cells (human lung adenocarcinoma), 
H1299 (human non-small lung cancer) and MCF-7 
(human breast adenocarcinoma), obtained from the 
American Type Culture Collection (ATCC).
MATERIALS AND METHODS
Plant material: The aerial parts of  P. alba L. and R. 
officinalis L. were collected from Gaziantep, south eastern 
Anatolia of  Turkey, and kept at laboratory conditions at 
room temperature (25°C) with no direct light until the 
extraction.
Extraction of  EOs: The leaves and flowers of  P. alba 
L. and R. officinalis L. were used for extraction of  EOs. 
All the plant parts (100 g for each plant species) were 
extracted separately by hydrodistillation using a Clev-
enger Apparatus for 4h at 100±5°C, and the extracted 
oils were dried over anhydrous Na2SO4, then the pure 
essential oils were obtained and stored at 4°C for 
further analysis. 
In vitro anticancer activity assay by MTT method: 
MTT assay was carried out to determine the potential 
antiproliferative and cytotoxic properties of  the EOs 
from P. alba  L. and R. officinalis L. against three human 
cancer cell lines: A549 cells (human lung adenocar-
cinoma), H1299 (human non-small cell lung cancer), 
MCF-7 (human breast adenocarcinoma), and non-tumor 
HUVEC cells, obtained from the American Type 
Culture Collection (ATCC). MTT assay was performed 
as previously reported by Al-Qubaisi et al.14 with minor 
modifications. Cells were cultured on RPMI-1640 
medium, supplemented with 10% fetal bovine serum, 
100 U/mL penicillin and 100 µg/mL streptomycin in 
the flasks with 5% CO2 at 37°C. The 5 x 10
3 cells per 
mL were treated with EOs with concentrations of  0, 
1, 10, 100 µM, and incubated at 37°C for 48h. After 
incubation, 50 µL/well of  MTT solution was added into 
each well, then the OD was measured at 570 nm and the 
inhibition (%) was calculated as;
[(mean OD without test agent (negative control) - mean 
OD with test agent / mean OD without test agent (negative 
control)] × 100
In vitro antioxidant activity assay by DPPH method: 
Antioxidant activity was determined using microplate 
2,2-diphenyl-2-picrylhydrazyl (DPPH) assay described 
by Molyneux15 with some modifications. Ascorbic acid 
was used as standard. The absorbance value was measured 
at 517 nm using a spectrophotometer in triplicate. The 
inhibition of  the DPPH scavenging activity was calcu-
lated using the following formula:
% DPPH scavenging activity = (1- A517 sample / A517 control) 
× 100
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Where Acontrol is the absorbance of  all the reagents 
except the test sample, Asample is the absorbance of  the 
EOs. Ascorbic acid was used as standard antioxidant. 
In order to determine IC50 values (scavenge 50% of  the 
DPPH radicals) of  the EOs, a linear regression analysis 
was used.
Lipid peroxidation activity assay by TBARS 
method: Lipid peroxidation activity was evaluated 
using thiobarbituric acid-reactive substances (TBARS) 
method described by Raharjo et al.16 and Ferreira et al.17, 
2-thiobarbituric acid (TBA) was used as indicator and 
1,1,3,3-tetraethoxypropane (TEP) as standard. The 
absorbance of  organic upper layer was read at 532 nm 
using a spectrophotometer in triplicate, and the TBARS 
values were expressed in terms of  malondialdehyde 
(MDA) equivalents for quantifying lipid peroxides. The 
lipid peroxidation inhibition was calculated as; 
Inhibition ratio (%) = (1- A532 sample / A532 control) × 100
Where Acontrol is the absorbance of  the control and 
Asample is the absorbance of  the sample solution. IC50 
values (50% of  the lipid peroxidation inhibition) of  the 
EOs were calculated and compared with the standard.
Statistical analysis: All the assays were conducted in 
triplicate, three different microplate wells were used to 
evaluate for each concentration of  the EOs. A linear 
regression analysis was performed to calculate IC50 
values. P value of  <0.01 was considered statistically very 
significant.
RESULTS AND DISCUSSION
The EOs from P. alba L. and R. officinalis L. were evaluated 
for their in vitro cytotoxic, antiproliferative, antioxidant 
and lipid peroxidation activities. Cytotoxicity (IC50 values 
after 48h treatment period) of  the EOs from P. alba 
L. and R. officinalis L. to three cancer cell lines (A549, 
H1299, and MCF-7) and to the non-tumor HUVEC 
cells are given in the Table 1.
The EOs of  P. alba L. and R. officinalis L. exhibited 
strong cytotoxic and antiproliferative properties against 
all the three tested human cancer cell lines, in a dose and 
time dependent manner. However, EO of  R. officinalis 
was found to be more active (IC50 values ranging from 
3.06 to 7.38 µg/mL) than that of  P. alba (IC50 values 
ranging from 12.05 to 28.16 µg/mL). Interestingly, 
the EOs from both plants showed a selectivity toward 
the cancer cell lines, exhibiting strong activity against 
A459 and H1299 cells, moderate activity against MCF-7 
and weak activity against the non-tumor HUVEC cells 
(IC50 > 30 µg/mL). The strong growth inhibition of  
EO from R. officinalis could be due to the presence of  
the cytotoxic components such as carnasol, methyl 
carnosate, carnosic and rosmarinic acids.5,6-9 Although this 
is the first report of  the cytotoxic and antiproliferative 
effects of  the EO from P. alba , it is probable that sapo-
nins, which are present in this EO, could contribute to 
these effect.13
The results of  in vitro antioxidant activity, expressed 
as IC50 values obtained from DPPH radical scavenging 
activity and lipid peroxidation activity by TBARS 
method, of  the EOs from P. alba  L. and R. officinalis 
L. are shown in Table 2. The EOs from both sources 
showed significant free radical scavenging activities 
against DPPH by when compared their values of  IC50 
with commercial with that of  ascorbic acid, a commercial 
standard AA (IC50 = 12.64 ± 0.32 µg/mL). The EO 
from R. officinalis L. was found to have higher free radical 
scavenging activity, with IC50 at 10.08 ± 0.15 µg/mL 
(p<0.01), 18.05 ± 0.38 µg/mL (p<0.05) Polyphenols 
and phenylpropanoids, found in the rosemary oil are 
most likely responsible for a strong radical scavenging 
activity.7,9,20 
The results of  lipid peroxides radical scavenging capacity 
for both of  the EOs, presented in Table 2, are consistent 
with the DPPH radical scavenging activity results. They 
were able to reduce the lipid peroxides radicals with IC50 
of  1.76 ± 0.02 and 2.16 ± 0.14 respectively (p<0.05). 
The values of  IC50 were compared with the commer-
cial standard BHT. This indicates that the rosemary and 
white poplar EOs were able to inhibit the free lipid 
Table 1: IC50 values, determined by MTT assay, of EOs from R. officinalis and P. alba.
Samples 
IC50 values from MTT (µg/mL)
A549 H1299 MCF-7 HUVEC
R. officinalis L. 3.06 ± 0.37 4.34 ± 0.44 7.38 ± 0.52 30.68 ± 2.80
P. alba  L. 12.05 ± 0.66 10.53 ± 0.38 28.16 ± 1.65 42.02 ± 2.04
Doxorubicina 0.25 ± 0.01 0.36 ± 0.02 0.82 ± 0.05 1.02 ± 0.02
DMSOb 0 0 0 0
Data are shown as means ± SD from three independent experiments (n=3). 
aDoxorubicin, positive control. 
bDMSO: negative control
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peroxides radicals, as well as the activities of  free radicals, 
this might be due to the fact that rich chemical composi-
tions of  the oils.5,13,20
CONCLUSION
However, further studies using cell culture and animal 
models to understand the mechanisms underlying the 
cytotoxicity and anticancer activity of  these EOs are 
needed to better understand the biological events and 
molecular targets of  EOs to safeguard their usage as 
therapeutic agents. In the near future, it would be possible 
to develop therapeutic drugs containing rosemary and 
white poplar EOs.
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SUMMARY
• EOs extracted from MAPs, are valuable sources due to their interesting anti-tumor, anti-
mutagenic and anti-carcinogenic activities against various cancer cells.
• Potential antioxidant properties, lipid peroxidation capacity, in vitro cytotoxic and antipro-
liferative activities of EOs extracted from P. alba L. and R. officinalis L. were evaluated in 
this research.
• To the best of our knowledge, this is the first report of EO of P. alba in vitro anticancer and 
antiproliferative activities.
• As a result, both of the EOs exhibited strong cytotoxic and antiproliferative properties 
against tested cancer cell lines. 
• Regarding antioxidant and lipid peroxidation activity, EO from R. officinalis L. was found to 
have higher antioxidant and lipid peroxidation capacities.
• This research clearly showed these oils have significant potential for developing therapeutic 
drugs in pharmaceutical industry.
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